|
Charts
|
Newsletters
|
Q&As
|
Trial Summaries
|
|
CARDIOLOGY
|
|
Hypertension
∙ ACE Inhibitors & ARBs
∙ Beta Blockers
∙ Calcium
Channel Blockers
∙ Diuretics
& Misc. Antihypertensives
∙ Summary:
Trials, Meds, Guidelines
|
∙ Hypertension
Update: Is anyone leaving samples of thiazide
diuretics?(Feb/03)
∙ Antihypertensive
Pharmacotherapy Update(Mar/00)
∙ Beta Blockers(Apr/98)
∙ Calcium
Channel Blockers(Dec/97)
∙ ACE-Inhibitors
& Angiotensin II Receptor Blockers(Oct/97)
|
∙ ARB’s & the Risk of Cancer(June/10)
∙ What’s
the Scoop on ACEI & ARB Combos Causing Harm?(Jan/09)
∙ Alternatives
to Nifedipine for Hypertensive Urgencies(May/98)
∙ Diuretics
for Hypertension(Mar/98)
|
∙ Summary(2010)
∙ ACCORD BP (Sept/10)
∙ ACCOMPLISH(Dec/08)
∙ ASCOT-BPLA(Sept/05)
∙ ANBP2(Mar/03)
∙ ALLHAT(Feb/03)
∙ Summary(2003)
|
|
Coagulation
∙ Antiplatelet/Antithrombotic Agents
|
|
∙ PPI’s
May Reduce Effectiveness of Clopidogrel (PLAVIX)(Jan/09)
|
∙ ARISTOTLE(Aug/11)
∙ Rocket-AF(Aug/11)
∙ Summary(2010)
∙ RE-LY(2010)
∙ ACTIVE-A,
ACTIVE-W(Sept/09)
∙
CLOPIDOGREL
- PPI
DI’s(Jan/09)
∙ CHARISMA(May/06)
|
|
Heart Failure
∙ Heart
Failure Therapy
|
∙ CFP Article – Targeting Success in HF: Evidence-Based
Management(Dec/10)
∙ Chronic
Heart Failure – Improving Outcomes and Preventing Admissions(May/09)
|
∙ Daily Weight Chart for HF Patients
∙ Furosemide Sliding Scale for HF Patients
|
∙ CHARM(Dec/03)
∙ ATLAS(1998)
|
|
Dyslipidemia/Cholesteremia
∙ Landmark
Lipid Trials
∙ Lipid
Lowering Agents
|
∙ Lipid-Lowering
Agents(Feb/02)
|
∙ Lipid
Therapy Update(Nov/04)
∙ Monitoring
Creatine Kinase in
Patients on Statin Therapy(Mar/02)
|
∙ AIM-HIGH(Dec/11)
∙ SHARP(Dec/11)
∙ Summary(2010)
∙ ACCORD Lipid(Sept/10)
∙ JUPITER(Nov/08)
∙ ENHANCE(June/08)
∙ SPARCL(Nov/06)
∙ IDEAL(Jan/06)
∙ Summary(2004)
∙ CARDS(Aug/04)
∙ PROVE-IT(May/04)
∙ ASCOT-LLA(Apr/03)
|
|
Myocardial Infarction
∙ Post-MI
Therapy
|
∙ Post-MI:
Troubleshooting Practical Issues(Oct/04)
|
∙ HQC – Post-MI Patient Education
Tool(2005)
|
|
|
Atrial Fibrillation
∙ QT
Prolongation / Torsades de Pointes
∙ 5-year
CVD Risk Assessment Tool
|
|
|
∙ ARISTOTLE(Aug/11)
∙ Rocket-AF(Aug/11)
∙ RE-LY(2010)
|
|
DERMATOLOGY
|
|
Various
∙ Acne Therapy
∙ Topical Corticosteroid Comparison
|
∙ CFP Article – Acne(Mar/09)
∙ Acne
Therapy(Mar/07)
∙ OTC
(Over-The-Counter) Products for Common Dermatological Conditions(Jan/04)
∙ Drug Therapy Issues: Topical
Steroids on the Face(May/03)
∙ Topical
Corticosteroids(May/98)
|
∙ Accutane Patient Monitoring Sheet
∙Hirsutism Treatment Chart (Idiopathic)
(Jan/2012)
∙Hirsutism Trial Summary (Background)
(Dec/2011)
|
|
|
EYE / EAR / NOSE / THROAT
|
|
Various
∙ Glaucoma
Topical Therapy
∙ Intranasal
Corticosteroid Comparison
|
∙ Intranasal
Corticosteroids & Allergic Rhinitis(Jan/04)
∙ Glaucoma:
Topical Treatment Tips(July/01)
|
|
∙ Vapor Rub, Petrolatum, and No Treatment for
Children with Nocturnal Cough and Cold(May/11)
|
|
ENDOCRINOLOGY
& METABOLISM
|
|
Andropause
∙ Testosterone Replacement Therapy
|
∙ Drug
Therapy Issues: Androgens in the Aging Male(May/03)
|
|
|
|
Diabetes
∙ Oral
Anti-hyperglycemic Agents
∙ Self-Monitoring
of Blood Glucose
∙ Insulin
Delivery Devices
∙ Insulin
Management & Tips
∙ Landmark
Diabetes Trials
|
∙
CFP
Article – Insulin & T2DM(June/09)
∙ Type
2 Diabetes: Update & Focus on Insulin Management Issues(Oct/08)
∙ Agents
for Type II Diabetes(Oct/01)
|
∙ Diabetes Overview Approach(Aug/11)
∙ Self-Monitoring of Blood Glucose Update(Oct/10)
∙ Sitagliptin
(JANUVIA) for T2DM(Nov/08)
∙ Diabetes
in Pregnancy and Gestational Diabetes(Oct/08)
∙ Diabetes:
Metformin Precautions (Renal, Hepatic, & Heart Failure)(Oct/08)
∙ Rosiglitazone (AVANDIA) &
Cardiovascular Risk(Dec/07)
∙ Diabetes
Prevention Summary(May/07)
∙ Hypoglycemic Drug Interactions(Oct/01)
∙ Renal
Care and Monitoring in Diabetes - Flowchart(Oct/01)
|
∙ Diabetes Landmark: Lipid, ASA, & BP
Trials Summary(Aug/11)
∙ Summary(2010)
∙ GLARGINE
& CANCER(July/09)
∙ RECORD(July/09)
∙ ACCORD(June/08)
∙ ADVANCE(June/08)
∙ ACCORD-ADVANCE(2008)
∙ DREAM(May/07)
|
|
Hirsutism
|
|
∙Hirsutism Treatment Chart (Idiopathic)
(Jan/2012)
∙Hirsutism Trial Summary (Background)
(Dec/2011)
|
|
|
Obesity
∙ Weight
Loss Drugs
∙ Herbal
Weight Loss Products
|
∙ Weight
Loss Drugs(Oct/06)
|
|
|
|
Thyroid Disorder
∙ Hyper/Hypothyroid
Treatment
|
|
|
|
|
GASTROINTESTINAL
|
|
Various
- Acid
Suppression (PPI’s, H2Ras)
∙ Crohn’s & Ulcerative Colitis
∙ GERD
& Peptic Ulcer Disease
∙ H. Pylori
Eradication
∙ Irritable Bowel
Syndrome
∙ Nausea
& Vomiting Management
|
∙ CFP Article – Navigating the
Complexity of Ulcerative Colitis(May/11)
∙ Irritable
Bowel Syndrome(Feb/08)
∙ Navigating
Acid Suppression Options - Optimal PPI Therapy(Sept/07)
∙ Gastric
Acid Suppression(May/99)
∙ H. Pylori
Eradication Regimens(Mar/99)
|
∙ PPI’s
May Reduce Effectiveness of Clopidogrel (PLAVIX)(Jan/09)
∙ Tegaserod – Limited Approval From the FDA for IBS(Aug/07)
|
|
|
GENITOURINARY
|
|
Various
∙ Erectile
Dysfunction Management
∙ Sexual
Dysfunction Management
∙ Treatment
of Urinary Incontinence
|
∙ CFP Article – Taking the Stress out of Treating Erectile
Dysfunction(Sept/10)
∙ Overactive
Bladder & Urinary Incontinence Comparison(Mar/08)
∙ Darifenacin
(ENABLEX) vs. Oxybutynin on Memory Impairment(Feb/08)
|
|
|
|
INFECTIOUS
DISEASE
|
|
Various
∙ Adult
Vaccinations Summary
∙ Antifungal
Agents
∙ Anti-Infectives for Common Infections
∙ Oral
Antibiotics Comparison
∙ Urinary
Tract Infections
|
∙ Onychomycosis Treatment Newsletter and Antifungal Drug
Chart(Apr/10)
∙ Zostavax (Shingles Prevention Vaccine)(Oct/09)
∙ Fluoroquinolones
– “Too Valuable to Overuse”(Feb/05)
∙ Acute
Otitis Media(Feb/01)
|
∙
Anti-Infective MUMs
Guidelines 2012 Changes(Jan/12)
∙Anti-Infective Update(Oct/10)
|
|
|
HIV
∙ Antiviral
HIV Therapy
|
|
|
|
|
Influenza
∙ Antiviral
Influenza Therapy
|
∙ Influenza
Overview Chart, Including Pandemic H1N1(Oct/09)
∙ Drugs
for Influenza(Sept/00)
|
∙ H1N1
(Swine Flu) Links(July/09)
∙ What To
Do About The FLU – A Patient’s Guide to Treatment &
Prevention(2000)
|
|
|
Malaria
∙ Malaria
Prophylaxis
|
|
|
|
|
Pneumonia
∙ Community-Acquired
Pneumonia
∙ Pneumonia
Severity Risk /
CURB-65
Diagnostic Tool
|
∙ Community
Acquired Pneumonia(Jan/01)
|
|
|
|
MUSCULOSKELETAL &
CONNECTIVE TISSUE
|
|
Pain
∙ Back
Pain Treatment
∙ Management
of Chronic, Non-Malignant Pain
∙ Gout
Therapy
∙ NSAIDs
& Other Analgesics
∙ Opioid
Comparison
∙ Pediatric
Pain Treatment
|
∙ CFP
Article – Opioids for Chronic Non-Cancer Pain in the Elderly(Aug/11)
∙ Opioids for Chronic Non-Cancer Pain(Mar/11)
∙ CFP
Article – Gout(Dec/09)
∙ Gout(Oct/09)
∙ Opioids
in Chronic Non-Malignant Pain – Troubleshooting Therapy Issues(Oct/05)
∙ COXIB’s in Clinical Practice: Towards a
Saskatchewan Consensus(May/02)
∙ COX-2
Inhibitors(Jan/00)
∙ NSAIDS
– Dare to Compare(July/97)
∙ Opioid Therapy Patient Agreement(pdf)
∙ Opioid Therapy Patient Agreement(word)
∙ Opioid Controlled Substance Clinic Policy(pdf)
∙ Opioid Controlled Substance Flow Sheet(pdf)
∙ Opioid Patch Disposal Tool(pdf)
|
∙ Acute vs Palliative vs
CNCP(Aug/11)
∙ Urine Drug Screening(Mar/11)
∙ Opioids for Pain in the Elderly(Mar/11)
∙ Analgesics in Acute Pain: Tips for Dentists & Physicians
2011(Mar/11)
∙ BUTRANS – Buprenorphine Transdermal
System(Aug/10)
∙ Handling
Back Pain Up-Front – Treatment Options(Apr/08)
∙ Lumiracoxib
(PREXIGE) and Hepatotoxicity(Aug/07)
∙ Chronic
Non-Malignant Pain – General Pharmacologic Considerations(Sept/05)
∙ Update
on Meloxicam (MOBICOX) & COX-2 Selectivity(Feb/01)
∙ Piroxicam-Beta-Cyclodextrin (BREXIDOL) Uncloaked!(Feb/00)
|
∙
Pain Control in Elderly Patients(Mar/11)
∙
Analgesics in Acute Pain: Tips for Dentists & Physicians
2011(Mar/11)
∙
COX-2
INHIBITORS(Feb/01)
|
|
Osteoporosis
∙ Treatment
of Osteoporosis
|
|
∙ Bisphosphonate Safety – SDIS Article(Nov/10)
∙ Osteoporosis/Vitamin D Update(Oct/10)
|
|
|
Arthritis
∙ Rheumatoid
Arthritis: DMARDs
|
|
|
|
|
NEPHROLOGY
|
|
Chronic Kidney Disease
∙ Landmark
Anemia Trials
∙ Erythropoietin
Comparison
∙ Iron
Replacement Therapy
∙ Phosphate
Binders
|
|
|
|
|
NEUROLOGY
|
|
Alzheimer’s
∙ Treament of Alzheimer’s/Dementia
|
∙ CFP Article – Behaviour Management in Dementia (Dec/11)
∙ Behaviour Management in Dementia: Where
Do Antipsychotics fit? (Oct 2011)
|
|
Catie-AD 2011
|
|
Multiple Sclerosis
∙ MS
Therapy
|
|
|
|
|
Parkinson’s
∙ Treatment
of Parkinson’s Disease
|
∙ Parkinson’s
Disease – Tips, Pearls & Comparisons(June/05)
|
|
|
|
Various
∙ Essential
Tremor & Restless Leg Syndrome
∙ Migraine:
Prophylaxis and Acute
∙ Seizures:
Antiepileptics
|
∙ CFP Article – Essential Tremor(Mar/10)
|
∙ List of Drugs With Anticholinergic
Effects(Apr/09)
|
|
|
OBSTETRICS
& GYNECOLOGY
|
|
Contraception
∙ Oral
Contraceptives Comparison
∙ Other
Hormonal Birth Control
|
∙ Hormonal
Contraception(Jan/00)
|
∙ Yaz & Yasmin – Safety
Considerations Related to VTE(Jan/11)
∙ Diane
35(Mar/00)
∙ Oral
Contraceptives – How Soon May They Be Used Post-Partum?(Feb/00)
|
|
|
Menopause
∙ Postmenopausal
Herbal Options
∙ Postmenopausal
Pharmacotherapy
|
∙ HRT:
Alternatives in Light of the WHI(Sept/02)
∙ Postmenopausal
Pharmacotherapy(Sept/99)
|
∙ Age
& the WHI (includes patient handout)(Nov/02)
∙ HRT
in Light of the WHI – Data in Perspective(Sept/02)
∙ Chronic
Unopposed Vaginal Estrogen Therapy(Oct/99)
∙ “Natural”
Hormone Replacement Therapy(Sept/99)
|
∙ WHI,
HERS, HERS II(2002)
∙ WHI
and Age(2002)
∙ WHI
Extras(2002)
|
|
OTC
& HERBAL MEDICATION
|
|
Various
∙ Info
on Cold-FX, Glucosamine, Lakota
∙ OTC
Remedies: Congestion,
Cough, Cold, Allergy, Dyspepsia, Constipation, Diarrhea, Pain Relief, Acne,
Fungal Infection, Dermatitis, Plantar Warts, Head Lice, Vitamins
∙ Herbal
Drug Interactions
|
∙ OTC
(Over-The-Counter) Products for Common Dermatological Conditions(Jan/04)
∙ Selecting
Cold Products Post Phenylpropanolamine(Nov/00)
|
∙ Vitamin
D – Review of the
Evidence(Nov/10)
∙ Vitamin D Overview(Oct/10)
∙ Energy Drinks(Oct/10)
|
∙ Vapor Rub, Petrolatum, and No Treatment for
Children with Nocturnal Cough and Cold(May/11)
|
|
PSYCHIATRY
|
|
Anxiety
∙ Anxiolytics Comparison
∙ Benzodiazepines
Comparison
|
|
|
|
|
Depression
∙ Antidepressant Drugs Comparison
∙ Antidepressant Drug Interactions
|
∙ Antidepressant
Agents(Oct/98)
|
∙ Can
ZYBAN (Buproprion) Be Given With SSRI’s?(Dec/98)
∙ Is
Fluoxetine Effective in the Treatment of PMS?(Dec/98)
∙ St.
John’s wort in the Treatment of Depression(Nov/98)
∙ Antidepressants
– Overview & Therapeutic Considerations(Oct/98)
|
|
|
Various
∙ ADHD
Treatment
∙ Bipolar
Disorder: Mood Stabilizers
∙ Hypersexuality Treatment Options
∙ Schizophrenia:
Antipsychotic Agents
∙
Sleep
Disorders: Sedative Agents
|
∙
CFP
Article – ADHD(Sep/09)
∙
ADHD Drug Therapy(Aug/08)
∙ Psychotropic
Drugs in the Elderly(May/01)
|
∙ ADHD Therapy Patient Agreement(pdf)
∙ ADHD Therapy Patient Agreement(word)
∙ Sedatives: Patient Info Tool(May/01)
|
|
|
RESPIRATORY
|
|
Asthma/COPD
∙ Asthma/COPD
Therapeutic Agents
∙ Asthma
Inhalational Devices
|
∙ Asthma
Treatment – Questions, Tips, Pearls, & Comparisons(Mar/06)
∙ Asthma
Pharmacotherapy(May/00)
∙ ASTHMA EDUCATORS IN SASKATCHEWAN –
CONTACT INFO(2010)
∙
HQC – Asthma
Action Plan(Patient Handout)
|
∙ Asthma(May/00)
∙ Asthma
Inhaler & Management Tips(May/00)
∙ Asthma:
Risk vs. Benefit of Alternative Therapies(May/00)
∙ COPD
– Pharmacotherapy Overview(May/00)
∙ COPD
& Corticosteroids(Feb/00)
|
∙ Summary(2006)
|
|
Various
∙ Smoking
Cessation
|
∙ Smoking
Cessation(Oct/06)
|
∙ Varenicline & CV Risk(July/11)
|
|
|
MISCELLANEOUS
|
|
∙ Cannabinoids:
An Overview
∙ Medication
Issues & Patient Safety
∙ Substance
Abuse, Addiction, & Treatment
∙ Drugs
Used in Transplantation
∙ Canadian
Health Agencies & Regulatory Bodies
∙ RxFiles
History, Overview of Academic Detailing
∙ Print
TOC, Index of Abbreviations and Pregnancy Classifications
|
∙ Drug
Resources for Hand-held PDA(May/06)
∙ Drug
Therapy Issues: Adverse Drug Reaction Reporting(May/03)
|
∙ Saskatchewan
Drug/Health Information Links(July/09)
∙ Does
Echinacea Interact With Prednisone?(Feb/00)
|
|